Effect of oxygen on growth of Mycobacterium ulcerans in the BACTEC system

Journal of Clinical Microbiology

Volumn 36, Issue 11, 1998, Pages 3420-3422

  Palomino, J C ^a   Obiang, A M ^a   Realini, L ^a   Meyers, W M ^b   Portaels, F ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBIC METABOLISM; ARTICLE; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIUM CULTURE; BACTERIUM ISOLATION; DEVICE; DIAGNOSTIC TEST; MYCOBACTERIUM ULCERANS; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TENSION; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); MYCOBACTERIUM ULCERANS; UNCULTURED ACTINOMYCETE;

EID: 0031697084     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.11.3420-3422.1998     Document Type: Article

References (17)

1. Aguiar, J., M. C. Domingo, A. Guedenon, W. Meyers, C. Steunou, and F. Portaels. 1997. L'ulcère de Buruli, une maladie mycobactérienne importante et en recrudescence au Benin. Bull. Séanc. Acad. Sci. Outre-Mer 43:325-356.
2. Clancey, J. K., O. G. Dodge, H. F. Lunn, and M. L. Odouri. 1961 Mycobacterial skin ulcers in Uganda. Lancet i:951-954.
3. Cornet, L., M. Richard-Kadio, H. A. N'Guessan, P. Yapo, H. Hossoko, R. Dick, and J. M. Casanelli. 1992. Treatment of Buruli ulcers by excision-graft. Bull. Soc. Pathol. Exot. 85:355-358.
4. Cunningham, A. F., and C. L. Spreadbury. 1998. Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton α-crystallin homolog. J. Bacteriol. 180:801-808.
5. Darie, H., T. Le Guyadec, and J. E. Touze. 1993. Epidemiological and clinical aspects of Buruli ulcer in Ivory Coast. 124 recent cases. Bull. Soc. Pathol. Exot. 86:272-276.
6. Goutzamanis, J. J., and G. L. Gilbert. 1995. Mycobacterium ulcerans infection in Australian children: report of eight cases and review. Clin. Infect. Dis. 21:1186-1192.
7. Josse, R., A. Guedenon, J. Aguiar, S. Anagonou, C. Zinsou, C. Prost, J. Foundohou, and J. E. Touze. 1994. Buruli ulcer, a pathology little known in Benin. Apropos of 227 cases. Bull. Soc. Pathol. Exot. 87:170-175.
8. Krieg, R. E., J. H. Wolcott, and W. M. Meyers. 1979. Mycobacterium ulcerans infection: treatment with rifampin, hyperbaric oxygenation and heat. Aviat. Space Environ. Med. 50:888-892.
9. Lindo, S. D., and S. F. Daniels. 1974. Buruli ulcer in New York City. JAMA 228:1138-1139.
10. Palomino, J. C., and F. Portaels. 1998. Effect of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the BACTEC system. J. Clin. Microbiol. 36:402-408.
11. Portaels, F., H. Traore, K. De Ridder, and W. M. Meyers. 1998. In vitro susceptibility of Mycobacterium ulcerans to clarithromycin. Antimicrob. Agents Chemother. 42:2070-2073.
12. Portaels, F., J. Aguiar, K. Fissette, P. A. Fonteyne, H. De Beenhouwer, P. de Rijk, A. Guedenon, R. Lemans, C. Steunou, C. Zinsou, J. M. Dumonceau, and W. M. Meyers. 1997. Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization. J. Clin. Microbiol. 35:1097-1100.
13. Portaels, F., P.-A. Fonteyne, H. de Beenhouwer, P. de Rijk, A. Guédénon, J. Hayman, and W. M. Meyers. 1996. Variability in 3′ end of 16S rRNA sequence of Mycobacterium ulcerans is related to geographic origin of isolates. J. Clin. Microbiol. 34:962-965.
14. Portaels, F., A. Guimaraes Peres, J. Aguiar, M. C. Domingo, P. de Rijk, A. Guédénon, K. Fissette, P. A. Fonteyne, C. Van Schaverbeeck, C. Steunou, and W. M. Meyers. Unpublished data.
15. Prasad, R. 1993. Pulmonary sarcoidosis and chronic cutaneous atypical mycobacterium ulcer. Aust. Fam. Physician 22:755-758.
16. Realini, L., K. De Ridder, J.-C. Palomino, B. Hirschel, and F. Portaels. 1998. Microaerophilic conditions promote growth of Mycobacterium genavense. J. Clin. Microbiol. 36:2565-2570.
17. Wayne, L. G., and L. G. Hayes. 1996. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64:2062-2069.